Literature DB >> 9670811

TGF-beta signaling, Smads, and tumor suppressors.

R W Padgett1, P Das, S Krishna.   

Abstract

The transforming growth factor-beta (TGF-beta) superfamily is used throughout animal development for regulating the growth and patterning of many tissue types. During the past few years, rapid progress has been made in deciphering how TGF-beta signals are transduced from outside the cell to the nucleus. This progress is based on biochemical studies in vertebrate systems and a combination of genetic studies in Drosophila and Caenorhabditis elegans. These studies have identified a novel family of signaling proteins, the Smad family. Smads can act positively and be phosphorylated by TGF-beta-like receptors or can act negatively and prevent activation of the positively acting group. The positively acting Smads translocate to the nucleus, bind DNA, and act as transcriptional activators. Thus, genetic and biochemical studies suggest a very simple signaling pathway, in which Smads are the primary downstream participant.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9670811     DOI: 10.1002/(SICI)1521-1878(199805)20:5<382::AID-BIES5>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  15 in total

1.  Transforming growth factor-β inhibition attenuates pulmonary arterial hypertension in rats.

Authors:  Aikaterini J Megalou; Chryssoula Glava; Dimitrios L Oikonomidis; Agapi Vilaeti; Maria G Agelaki; Giannis G Baltogiannis; Apostolos Papalois; Antonios P Vlahos; Theofilos M Kolettis
Journal:  Int J Clin Exp Med       Date:  2010-10-23

2.  Competing roles of TGFbeta and Nma/BAMBI in odontoblasts.

Authors:  C B Gonzales; D Simmons; M MacDougall
Journal:  J Dent Res       Date:  2010-02-19       Impact factor: 6.116

Review 3.  TGF-β signaling in C. elegans.

Authors:  Tina L Gumienny; Cathy Savage-Dunn
Journal:  WormBook       Date:  2013-07-10

4.  Human pancreatic islets express mRNA species encoding two distinct catalytically active isoforms of group VI phospholipase A2 (iPLA2) that arise from an exon-skipping mechanism of alternative splicing of the transcript from the iPLA2 gene on chromosome 22q13.1.

Authors:  Z Ma; X Wang; W Nowatzke; S Ramanadham; J Turk
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

5.  Genetic analysis of the bone morphogenetic protein-related gene, gbb, identifies multiple requirements during Drosophila development.

Authors:  K A Wharton; J M Cook; S Torres-Schumann; K de Castro; E Borod; D A Phillips
Journal:  Genetics       Date:  1999-06       Impact factor: 4.562

6.  egl-4 acts through a transforming growth factor-beta/SMAD pathway in Caenorhabditis elegans to regulate multiple neuronal circuits in response to sensory cues.

Authors:  S A Daniels; M Ailion; J H Thomas; P Sengupta
Journal:  Genetics       Date:  2000-09       Impact factor: 4.562

7.  Characterization of a bone morphogenetic protein-responsive Smad-binding element.

Authors:  K Kusanagi; H Inoue; Y Ishidou; H K Mishima; M Kawabata; K Miyazono
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

8.  Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta.

Authors:  C Wong; E M Rougier-Chapman; J P Frederick; M B Datto; N T Liberati; J M Li; X F Wang
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

9.  Drosophila screening model for metastasis: Semaphorin 5c is required for l(2)gl cancer phenotype.

Authors:  Elisa C Woodhouse; Amy Fisher; Russell W Bandle; Bianca Bryant-Greenwood; Lula Charboneau; Emanuel F Petricoin; Lance A Liotta
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-19       Impact factor: 11.205

10.  Biemamides A-E, Inhibitors of the TGF-β Pathway That Block the Epithelial to Mesenchymal Transition.

Authors:  Fan Zhang; Doug R Braun; Gene E Ananiev; F Michael Hoffmann; I-Wei Tsai; Scott R Rajski; Tim S Bugni
Journal:  Org Lett       Date:  2018-08-30       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.